User profiles for Firoza Z. Lussier
 | Firoza Zubeida LussierMcGill University Verified email at mail.mcgill.ca Cited by 2400 |
Microglial activation and tau propagate jointly across Braak stages
…, J Therriault, M Chamoun, M Savard, FZ Lussier… - Nature medicine, 2021 - nature.com
Compelling experimental evidence suggests that microglial activation is involved in the spread
of tau tangles over the neocortex in Alzheimer’s disease (AD). We tested the hypothesis …
of tau tangles over the neocortex in Alzheimer’s disease (AD). We tested the hypothesis …
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease
An unresolved question for the understanding of Alzheimer’s disease (AD) pathophysiology
is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) …
is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) …
Biomarker modeling of Alzheimer's disease using PET-based Braak staging
Gold-standard diagnosis of Alzheimer’s disease (AD) relies on histopathological staging
systems. Using the topographical information from [ 18 F]MK6240 tau positron-emission …
systems. Using the topographical information from [ 18 F]MK6240 tau positron-emission …
18F-MK-6240 PET for early and late detection of neurofibrillary tangles
Braak stages of tau neurofibrillary tangle accumulation have been incorporated in the
criteria for the neuropathological diagnosis of Alzheimer’s disease. It is expected that Braak …
criteria for the neuropathological diagnosis of Alzheimer’s disease. It is expected that Braak …
Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography
Importance The recent proliferation of phosphorylated tau (p-tau) biomarkers has raised
questions about their preferential association with the hallmark pathologies of Alzheimer …
questions about their preferential association with the hallmark pathologies of Alzheimer …
APOEε4 associates with microglial activation independently of Aβ plaques and tau tangles
Animal studies suggest that the apolipoprotein E ε4 (APOEε4) allele is a culprit of early
microglial activation in Alzheimer’s disease (AD). Here, we tested the association between …
microglial activation in Alzheimer’s disease (AD). Here, we tested the association between …
Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals
FZ Lussier, TA Pascoal, M Chamoun… - Alzheimer's & …, 2020 - Wiley Online Library
Introduction Mild behavioral impairment (MBI) is characterized by the emergence of
neuropsychiatric symptoms in elderly persons. Here, we examine the associations between MBI and …
neuropsychiatric symptoms in elderly persons. Here, we examine the associations between MBI and …
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages
…, J Therriault, S Mathotaarachchi, M Savard, FZ Lussier… - Brain, 2021 - academic.oup.com
Tracking longitudinal tau tangles accumulation across the Alzheimer’s disease continuum is
crucial to better understand the natural history of tau pathology and for clinical trials. …
crucial to better understand the natural history of tau pathology and for clinical trials. …
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's disease
Astrocytes can adopt multiple molecular phenotypes in the brain of Alzheimer’s disease (AD)
patients. Here, we studied the associations of cerebrospinal fluid (CSF) glial fibrillary acidic …
patients. Here, we studied the associations of cerebrospinal fluid (CSF) glial fibrillary acidic …
Comparing tau status determined via plasma pTau181, pTau231 and [18F] MK6240 tau-PET
Background Tau in Alzheimer's disease (AD) is assessed via cerebrospinal fluid (CSF) and
Positron emission tomography (PET). Novel methods to detect phosphorylated tau (pTau) in …
Positron emission tomography (PET). Novel methods to detect phosphorylated tau (pTau) in …
